Measuring psychosocial outcomes in schizophrenia patients

被引:52
作者
Figueira, Maria L. [1 ]
Brissos, Sofia [2 ]
机构
[1] Univ Lisbon, Hosp Santa Maria, Fac Med, Dept Psychiat, P-1649035 Lisbon, Portugal
[2] Lisbons Psychiat Hosp Ctr, Lisbon, Portugal
关键词
functioning; outcome measures; personal; schizophrenia; social; STANDARDIZED REMISSION CRITERIA; SERIOUS MENTAL-ILLNESS; QUALITY-OF-LIFE; FUNCTIONAL RECOVERY; ASSESSMENT SCALE; SELF-REPORT; DSM-IV; PERFORMANCE; RELIABILITY; ANTIPSYCHOTICS;
D O I
10.1097/YCO.0b013e3283438119
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Purpose of review Improvement in psychosocial functioning is nowadays considered an important and achievable goal of schizophrenia treatment. Therefore, treatment interventions are expected to have a positive influence both on symptoms and on social integration. In this nonsystematic literature review, we describe some of the available measures to assess social outcomes in schizophrenia treatment and their inherent limitations, and discuss future directions for research and clinical practice. Recent findings The lack of consensus on the appropriate terminology and standards applied to index patients' level of functioning remains an obstacle in assessing psychosocial outcomes in schizophrenia. Although some scales appear advantageous in terms of ease of administration and reliability, they lack enough solid evidence that they are related to real-world outcomes or sensitive to change. Performance-based measures are being more widely used to assess functional capacity because they appear effective in predicting independent living and work, as compared with both self-report and clinical measures. Summary We argue that assessment of psychosocial functioning should be an integral part of schizophrenia patients' assessment, in both the research and clinical setting. Ultimately, there exists no gold standard measure, but, of those available, the Personal and Social Performance (PSP) Scale and the UCSD Performance-based Skills Assessment (UPSA) have literature supporting their usefulness for assessing psychosocial outcomes in schizophrenia patients.
引用
收藏
页码:91 / 99
页数:9
相关论文
共 63 条
[1]   Designing outcome studies to determine efficacy and safety of antipsychotics for 'real world' treatment of schizophrenia [J].
Altamura, A. Carlo ;
Glick, Ira D. .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 (07) :971-973
[2]   Remission in schizophrenia: Proposed criteria and rationale for consensus [J].
Andreasen, NC ;
Carpenter, WT ;
Kane, JM ;
Lasser, RA ;
Marder, SR ;
Weinberger, DR .
AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (03) :441-449
[3]  
Andreasen NC, 2006, ACTA PSYCHIAT SCAND, V113, P81, DOI 10.1111/j.1600-0447.2005.00688.x
[4]  
[Anonymous], 2000, WHO DISABILITY ASSES
[5]  
[Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787
[6]  
[Anonymous], 2001, INT CLASS FUNCT DIS
[7]  
Atkinson M, 1997, AM J PSYCHIAT, V154, P99
[8]   Psychosocial remission in schizophrenia: developing a clinician-rated scale [J].
Barak, Yoram ;
Bleich, Avi ;
Aizenberg, Dov .
COMPREHENSIVE PSYCHIATRY, 2010, 51 (01) :94-98
[9]   Recovery from schizophrenia: Results from a 1-year follow-up observational study of patients in symptomatic remission [J].
Bobes, Julio ;
Ciudad, Antonio ;
Alvarez, Enric ;
San, Luis ;
Polavieja, Pepa ;
Gilaberte, Inmaculada .
SCHIZOPHRENIA RESEARCH, 2009, 115 (01) :58-66
[10]   Association between symptomatic remission and functional outcome in first-episode schizophrenia [J].
Boden, Robert ;
Sundstrom, Johan ;
Lindstrom, Eva ;
Lindstrom, Leif .
SCHIZOPHRENIA RESEARCH, 2009, 107 (2-3) :232-237